A new era for cancer immunotherapy based on the genes that encode cancer antigens

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Cancer research·1992

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Journal of immunotherapy : official journal of the Society for Biological Therapy·1992

The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.

Annals of oncology : official journal of the European Society for Medical Oncology·1992

Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.

Journal of immunotherapy : official journal of the Society for Biological Therapy·1992

The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.

Journal of immunotherapy : official journal of the Society for Biological Therapy·1992

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

Journal of immunology (Baltimore, Md. : 1950)·1992

Sensory nerves send lymphoid assembly up in smoke.

Immunity·2026

Speedy delivery: EV-derived fungal antigens establish oral-gut Th17 crosstalk.

Immunity·2026

Chromatin triggers tissue-specific immunity in 3D.

Immunity·2026

Lending an ear to the lung.

Immunity·2026

A pulmonary innate lymphoid cell-driven serotonergic neuroimmune axis orchestrates airway hyperreactivity and cough hypersensitivity.

Immunity·2026

Twenty-year persistence of SARS-CoV-1 immune imprinting shapes antibody responses to SARS-CoV-2 infection.

Immunity·2026

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

European journal of nuclear medicine and molecular imaging·2026

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

Gut·2026

Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

Journal of Crohn's & colitis·2026

Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.

Biochimica et biophysica acta. Reviews on cancer·2026

Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

Biochimica et biophysica acta. Reviews on cancer·2026

Related Experiment Videos

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Related Concept Videos

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.

Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.

The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

Sensory nerves send lymphoid assembly up in smoke.

Speedy delivery: EV-derived fungal antigens establish oral-gut Th17 crosstalk.

Chromatin triggers tissue-specific immunity in 3D.

Lending an ear to the lung.

A pulmonary innate lymphoid cell-driven serotonergic neuroimmune axis orchestrates airway hyperreactivity and cough hypersensitivity.

Twenty-year persistence of SARS-CoV-1 immune imprinting shapes antibody responses to SARS-CoV-2 infection.

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.

Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

Related Experiment Videos

A new era for cancer immunotherapy based on the genes that encode cancer antigens

Related Concept Videos

Related Articles